Access to anti-retroviral drugs, female in Nigeria
Nigeria: Access to anti-retroviral drugs, female was 89.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Nigeria, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Nigeria stood at 89.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.7% on the previous year and up 102.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Nigeria peaked at 89.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Nigeria 35th out of 141 countries with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Nigeria, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 1.0% | +0.0% |
| 2004 | 2.0% | +100.0% |
| 2005 | 3.0% | +50.0% |
| 2006 | 6.0% | +100.0% |
| 2007 | 7.0% | +16.7% |
| 2008 | 13.0% | +85.7% |
| 2009 | 17.0% | +30.8% |
| 2010 | 21.0% | +23.5% |
| 2011 | 24.0% | +14.3% |
| 2012 | 34.0% | +41.7% |
| 2013 | 39.0% | +14.7% |
| 2014 | 44.0% | +12.8% |
| 2015 | 47.0% | +6.8% |
| 2016 | 53.0% | +12.8% |
| 2017 | 56.0% | +5.7% |
| 2018 | 55.0% | -1.8% |
| 2019 | 61.0% | +10.9% |
| 2020 | 67.0% | +9.8% |
| 2021 | 73.0% | +9.0% |
| 2022 | 79.0% | +8.2% |
| 2023 | 85.0% | +7.6% |
| 2024 | 89.0% | +4.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.0% | 0.0% | 17.0% | 10 |
| 2010s | 43.4% | 21.0% | 61.0% | 10 |
| 2020s | 78.6% | 67.0% | 89.0% | 5 |
Countries ranked near Nigeria
More gender data for Nigeria
- Child population (UN estimates and projections) 99,803 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.6887 % change on previous year (2030)
- Population 162,578 (2030)
- Working-age population (UN estimates and projections) 162,578 (2030)
- Population (UN estimates and projections), annual growth rate 2.75 % change on previous year (2030)
- Age population, age 00, female, interpolated 3.55 million (2025)
- Age population, age 00, male, interpolated 3.66 million (2025)
- Age population, age 01, female, interpolated 3.45 million (2025)
- Age population, age 01, male, interpolated 3.54 million (2025)
- Age population, age 02, female, interpolated 3.38 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Nigeria?
- Access to anti-retroviral drugs, female in Nigeria was 89.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Nigeria?
- The highest recorded value was 89.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Nigeria?
- The lowest recorded value was 0.0% in 2000.
- How does Nigeria rank for access to anti-retroviral drugs, female?
- Nigeria ranks 35th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Nigeria?
- Over the last ten years it is up 102.3%. The long-run trend across the full record is volatile.
- Where does this Nigeria data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.